The firm is currently examining the merger between NOVAGOLD RESOURCES INC. and Donlin Gold LLC, as well as the sale of BioLife Solutions, Inc. to Repligen Corporation. Under the terms of the BioLife agreement, shareholders are slated to receive $11.25 per share in cash supplemented by 0.1442 shares of Repligen common stock. Additionally, the investigation covers the merger involving Northrim BanCorp, Inc. and PBCO Financial Corporation.

Legal representatives for the firm suggest that these deals may contain restrictive terms that hinder superior competing offers or provide disproportionate benefits to insiders. The firm, led by Daniel Sadeh and Zachary Halper, is evaluating whether to pursue litigation to secure increased compensation or enhanced disclosures for investors. These inquiries operate on a contingent fee basis, meaning shareholders face no out-of-pocket costs to participate in the review of their rights.